Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03226249
Title PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

Hodgkin's lymphoma

Therapies

Dacarbazine + Doxorubicin + Pembrolizumab + Vinblastine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.